Cipla Company Profile

✉ Email this page to a colleague

CIPLA has ninety-one approved drugs.

There are six US patents protecting CIPLA drugs. There are thirty-three tentative approvals on CIPLA drugs.

There are thirty patent family members on CIPLA drugs in twenty-one countries and four hundred and thirty-nine supplementary protection certificates in seventeen countries.

International Patents:	30
US Patents:	6
Tradenames:	80
Ingredients:	80
NDAs:	91
Patent Litigation for Cipla:	See patent lawsuits for Cipla
PTAB Cases with Cipla as petitioner:	See PTAB cases with Cipla as petitioner

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cipla	CASPOFUNGIN ACETATE	caspofungin acetate	POWDER;INTRAVENOUS	209489-001	Jul 12, 2018		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Cipla	TERBINAFINE HYDROCHLORIDE	terbinafine hydrochloride	TABLET;ORAL	077137-001	Jul 2, 2007		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Cipla	CINACALCET HYDROCHLORIDE	cinacalcet hydrochloride	TABLET;ORAL	208915-001	Mar 8, 2018	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Cipla	CELECOXIB	celecoxib	CAPSULE;ORAL	207446-003	Sep 23, 2015	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Cipla	BUDESONIDE	budesonide	SUSPENSION;INHALATION	205710-003	Nov 16, 2017	AN	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2008045410	⤷ Sign Up
Portugal	2217610	⤷ Sign Up
Cyprus	1118915	⤷ Sign Up
Australia	2008326297	⤷ Sign Up
European Patent Office	3150617	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1419152	12C0036	France	⤷ Sign Up	PRODUCT NAME: COMBINAISON DE RILPIVIRINE ET TOUTES SES FORMES THERAPEUTIQUEMENT EQUIVALENTES PROTEGEES PAR LE BREVET DE BASE, TELLES QUE LES SELS D'ADDITION PHARMACEUTIQUEMENT ACCEPTABLES DE RILPIVIRINE, Y COMPRIS LE SEL D'ACIDE CHLORHYDRIQUE DE RILPIVIRINE ET DE TENOFOVIR, EN PARTICULIER LE TENOFOVIR DISOPROXIL FUMARATE; REGISTRATION NO/DATE: EU/1/11/737/001 20111128
0914118	PA2007001	Lithuania	⤷ Sign Up	PRODUCT NAME: DEFERASIROXUM; REGISTRATION NO/DATE: EU/1/06/356/001 2006 08 28, EU/1/06/356/002 2006 08 28, EU/1/06/356/003 2006 08 28, EU/1/06/356/004 2006 08 28, EU/1/06/356/005 2006 08 28, EU/1/06/356/00 20060828
2487163	60/2016	Austria	⤷ Sign Up	PRODUCT NAME: COBICISTAT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON UND ATAZANAVIR ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE ATAZANAVIR-SULFAT; REGISTRATION NO/DATE: EU/1/15/1025 (MITTEILUNG) 20150715
0934061	PA2004017	Lithuania	⤷ Sign Up	PRODUCT NAME: PREGABALINUM ((S)-3-(AMINOMETIL)-5-METILHEKSANO RÃ»GÃ°TIS)
1131065	1490039-3	Sweden	⤷ Sign Up	PRODUCT NAME: DIMETHYL FUMARATE; REG. NO/DATE: EU/1/13/837 20140130
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.